Kaival Brands, the U.S. distributor of products manufactured by Bidi Vapor, expects an increase in sales of their Bidi Stick vapor product following a recent court ruling in the United States. The U.S. Food and Drug Administration (FDA) will be revisiting the pre-market tobacco product application (PMTA) for the company.
On August 23rd, six companies, including Bidi Vapor and Diamond Vapor, filed a petition for review with the 11th Circuit Court of Appeals, questioning the FDA's rejection of their e-cigarette applications. According to Chief Judge William Pryor, the agency failed to properly evaluate these companies' marketing and sales access restriction plans aimed at minimizing youth exposure and access.
This ruling effectively overturns the order to cease marketing and allows Bidi Vapor to continue selling all flavor varieties of Bidi Stick in the United States. The company submitted PMTA for all 11 Bidi Stick flavors prior to September. The PMTA deadline was on September 9, 2020.
Eric Mosser, President and Chief Operating Officer of Kaival Brands, announced that the decision to become the exclusive distributor of Bidi Vapor products in the United States is a significant milestone for the company and its downstream partners. This decision paves the way for potential revenue growth and many have been eagerly awaiting the expansion of distribution.
But not only that, we are pleased that the appellate court recognizes the potential importance and direct impact of marketing programs focused on adults and strict sales and access restrictions in addressing youth access issues.
At the time of publication, the FDA had not announced how they will respond to the court ruling. The agency may appeal the decision or conduct a scientific review of Bidi Vapor's non-tobacco flavored devices' PMTA.
Statement:
This article is compiled from third-party information and is intended for industry discussion and learning purposes only.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is intended solely for industry exchange and research purposes.
Due to the limited ability to translate, the translated article may not represent the original text accurately. Please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expression and position.
The compiled information is copyrighted by the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
